Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Levi Pierce

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Protein Science : a Publication of the Protein Society|August 19, 2014
Trypsinogen activation as observed in accelerated molecular dynamics simulationsLeonardo Boechi, Levi Pierce, Elizabeth A Komives, et al.
The Journal of Physical Chemistry. B|February 15, 2012
Dynamics and calcium association to the N-terminal regulatory domain of human cardiac troponin C: a multiscale computational studySteffen Lindert, Peter M Kekenes-Huskey, Gary Huber, et al.
Journal of Chemical Theory and Computation|July 26, 2014
Improved Reweighting of Accelerated Molecular Dynamics Simulations for Free Energy CalculationYinglong Miao, William Sinko, Levi Pierce, et al.
Protein Science : a Publication of the Protein Society|November 10, 2012
Structural insight into the separate roles of inositol tetraphosphate and deacetylase-activating domain in activation of histone deacetylase 3Mehrnoosh Arrar, Rigney Turnham, Levi Pierce, et al.
Journal of the American Chemical Society|January 28, 2015
Accurate and reliable prediction of relative ligand binding potency in prospective drug discovery by way of a modern free-energy calculation protocol and force fieldLingle Wang, Yujie Wu, Yuqing Deng, et al.
Cancer Discovery|November 2, 2023
Allosteric PI3Kα Inhibition Overcomes On-target Resistance to Orthosteric Inhibitors Mediated by Secondary PIK3CA MutationsAndreas Varkaris, Ferran Fece de la Cruz, Elizabeth E Martin, et al.
Journal of Medicinal Chemistry|September 29, 2023
Identification of GDC-1971 (RLY-1971), a SHP2 Inhibitor Designed for the Treatment of Solid TumorsAlexander M Taylor, Bret R Williams, Fabrizio Giordanetto, et al.
Cancer Discovery|November 2, 2023
Discovery and Clinical Proof-of-Concept of RLY-2608, a First-in-Class Mutant-Selective Allosteric PI3Kα Inhibitor That Decouples Antitumor Activity from HyperinsulinemiaAndreas Varkaris, Ermira Pazolli, Hakan Gunaydin, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Protein Science : a Publication of the Protein Society|August 19, 2014
Trypsinogen activation as observed in accelerated molecular dynamics simulationsLeonardo Boechi, Levi Pierce, Elizabeth A Komives, et al.
The Journal of Physical Chemistry. B|February 15, 2012
Dynamics and calcium association to the N-terminal regulatory domain of human cardiac troponin C: a multiscale computational studySteffen Lindert, Peter M Kekenes-Huskey, Gary Huber, et al.
Journal of Chemical Theory and Computation|July 26, 2014
Improved Reweighting of Accelerated Molecular Dynamics Simulations for Free Energy CalculationYinglong Miao, William Sinko, Levi Pierce, et al.
Protein Science : a Publication of the Protein Society|November 10, 2012
Structural insight into the separate roles of inositol tetraphosphate and deacetylase-activating domain in activation of histone deacetylase 3Mehrnoosh Arrar, Rigney Turnham, Levi Pierce, et al.
Journal of the American Chemical Society|January 28, 2015
Accurate and reliable prediction of relative ligand binding potency in prospective drug discovery by way of a modern free-energy calculation protocol and force fieldLingle Wang, Yujie Wu, Yuqing Deng, et al.
Cancer Discovery|November 2, 2023
Allosteric PI3Kα Inhibition Overcomes On-target Resistance to Orthosteric Inhibitors Mediated by Secondary PIK3CA MutationsAndreas Varkaris, Ferran Fece de la Cruz, Elizabeth E Martin, et al.
Journal of Medicinal Chemistry|September 29, 2023
Identification of GDC-1971 (RLY-1971), a SHP2 Inhibitor Designed for the Treatment of Solid TumorsAlexander M Taylor, Bret R Williams, Fabrizio Giordanetto, et al.
Cancer Discovery|November 2, 2023
Discovery and Clinical Proof-of-Concept of RLY-2608, a First-in-Class Mutant-Selective Allosteric PI3Kα Inhibitor That Decouples Antitumor Activity from HyperinsulinemiaAndreas Varkaris, Ermira Pazolli, Hakan Gunaydin, et al.
Pageof 1